New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
October 6, 2017 – Flexion Therapeutics announced the FDA approval of Zilretta (triamcinolone acetonide) extended-release injection, for the management of osteoarthritis (OA) pain of the knee.
Download PDF
Return to publications
